Lack of resources, financial difficulties remain top barriers to patient portal implementation

Lacking resources and financial difficulties were reported as the top factors hindering implementation of patient portals, according to a study published in the Journal of Medical Internet Research.

In the study, researchers identified barriers and facilitators leading to the successful implementation of patient portals within hospitals in the Netherlands.

“Previous research focused on patient involvement in developing the portals, but little is yet known about organizational factors that facilitate or hinder patient portal implementation,” wrote first author Laura Kooij, MSc, and colleagues. “Such knowledge is essential because the number of portals is rising. Comprehensive information can provide a framework for upcoming patient portal implementations, or other eHealth applications, in hospitals.”

Researchers analyzed two university medical centers, three teaching hospitals and two general hospitals while also interviewing 21 stakeholders from three locations. In total, 376 quotes, 26 barriers and 28 facilitators were identified.

 

Facilitators perceived usefulness and a subject’s positive attitude led to successful implementations of patient portals. However, lack of resources, financial difficulties and privacy and security concerns were identified as the main barriers to implementation.

“Patient portal implementation is a complex process and is not only a technical process but also affects the organization and its staff,” concluded Kooji and colleagues. “Barriers and facilitators occurred at various levels and differed among hospital types (lack of accessibility) and stakeholder groups (sufficient resources) in terms of several factors. Our findings underscore the importance of involving multiple stakeholders in portal implementations. We identified a set of barriers and facilitators that are likely to be useful in making strategic and efficient implementation plans.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.